Traditionally, ocular surface cytology is studied with techniques such as spatula technology and brush technology. The problem with these techniques is that they may induce traumatic lesions on the surface of the eye, which can progress to scarring, eyelid deformity, limbal stem cell deficiency and in some cases, cause great discomfort to the subject. To avoid these clinical problems, impression cytology (IC) was developed to diagnose dry eye disease and later neoplasia, atopic disease, vernal keratoconjunctivitis and keratoconjunctivitis sicca. Typically, clinicians manually cut filter papers into required shapes and apply these to the ocular surface. Here, we describe how to perform IC using a commercially available medical device. This technique is explained here followed by immunophenotyping by flow cytometry. This technique requires less manual handling and causes less injury to the ocular surface.
Introduction
Impression cytology (IC) was first performed in 1977 by Thatcher et al 1 . They used a plastic impression disc to collect conjunctival cells from patients instead of other techniques available at that time such as scraping, swabbing or pipetting 1 . The current technique of IC uses an absorbent filter paper 2 to imprint the bulbar and palpebral conjunctiva and collect the most superficial layer of conjunctival cells. These cells, having reached their final stage of differentiation, are continuously shed into tears 3 . Three major populations of cells are found in IC specimens: epithelial cells 4 , goblet cells 3, 5 , and mucosal-associated lymphoid tissue viz epithelium-associated effector T cells or dendritic cells 6 . Ocular surface cells in IC samples can be analyzed by microscopy, immune-blotting and reverse-transcriptase polymerase chain reaction (RT-PCR) 7 . Flow cytometry has been recently used to analyze immune cells collected by scraping the IC membrane 8 . Interestingly, IC 6, 9 has been used to evaluate many ocular surface diseases including keratoconjunctivitis sicca, vitamin A deficiency, cicatricial pemphigoid, atopic disease, superior limbic keratoconjunctivitis, vernal keratoconjunctivitis, and epithelial squamous metaplasia. IC has also been used to evaluate the impact of wearing contact lenses, detecting ocular surface microbes, and testing therapeutic efficacy and tolerance of therapeutic interventions in longitudinal studies 10, 11, 12 .
The medical device (EyePrim) is supported by a type of polyethersulfone (PES) 0.2-µm membrane, which has been previously validated for the technique of ocular impression cytology with flow cytometry (OSIC-flow) and opens up opportunities to use longitudinal sampling to monitor disease progression and response to treatment (e.g., the detailed analysis of intraepithelial leukocytes defined as putative disease markers for progressive conjunctival fibrosis in mucous membrane pemphigoid) 13 . Early researchers used autoclaved PES filters that required manual impression. As a result, the yield was variable and user dependent. The advantage of this medical device is ease of use, standardized pressure (Pa or N/m 2 ), and enables repeatability, reproducibility, and consistent cellular recovery. This technique is useful in an out-patient clinic because it is non-surgical, easy-to-perform and rapid. This is a Class I (sterile) medical device according to the directive 93/42/CEE, CE 0499 (SNCH). It only requires topical anesthesia during the procedure, which ensures maintenance of the integrity of the ocular surface. Following IC, cells can be processed immediately for flow cytometry. Moreover, it is possible for non-ophthalmology technicians and nurses to be trained to sample the ocular surface.
Protocol
All ocular samples used in this study were collected from the Dry Eye Clinic at the Singapore National Eye Centre approved by SingHealth Centralized Institutional Review Board and the Nanyang Technological University Institutional Review Board, Singapore.
NOTE: Subjects underwent clinical tests to assess the extent of inflammation and the severity of tear dysfunction before IC was performed. Clinical tests included non-invasive tear break-up time (NI-TBUT) 14 and conjunctival redness (hyperemia) 15 
Collection of Ocular Samples by IC
1. After determination of the clinical status, anesthetize the participant's eyes by applying 1 -2 drops of topical anesthesia, proparacaine hydrochloride, to the superior bulbar conjunctiva and inferior fornix. Wait for 4 -5 min for the stinging sensation of the anesthetic to wear off. 2. Collect samples from both nasal and temporal bulbar conjunctiva with two impression cytology devices.
NOTE: One device is used for the collection of two impression samples. Here, two devices were used for the collection of four impression membranes.
1. Position the impression cytology device tangentially on the conjunctiva. Press the push-button gently and hold for 2 -3 s. NOTE: The device comes with the membrane. Pressure is released automatically after pushing the button. It takes only few seconds to release the pressure and remove the device. 20 For testing, PBMCs were incubated with the same set of antibodies used here and compensated by comparing single and multiple antibody stains. 3. After the incubation period, add 1 mL of staining buffer to the tube, mix well, and centrifuge at 450 x g for 5 min at room temperature.
Resuspend cells in 200 µL of staining buffer. 4. Run samples on a flow cytometry machine.
1. Before acquiring the data, calibrate the flow cytometer channel voltages with cytometer setup and tracking (CS&T) beads to normalize the data acquisition on different days as per manufacturer's instructions. 1. Open the flow cytometry data collection software, click "Set up & QC" button, choose the correct CS&T bead lot number, load the beads, and then click the "Start" button.
2. Resuspend cells by gently tapping the tube before loading samples to the machine. Open the data collection software and click "Preview". When threshold rate is stable, click "Acquire". Monitor the sample level and click "Stop" when samples run out. NOTE: Acquire 10,000 events per sample. 3. After acquiring 10,000 events, generate a SSC-A and FSC-A dot plot in the worksheet.
1. Click the "Polygon Gate" button and draw a gate (this is P1) over all events with a FSC-A value > 5 x 10 4 to exclude debris. Click "Create dot plot" button to generate a new dot plot, right click the dot blot, choose "Properties" to open the "Plot Editor" window, and then choose "P1". Click the FSC-A on x-axis of P1 dot plot, change it to CD3-BV510. Draw a ''Polygon Gate'' to choose the CD3 + population and name it ''P2''. ). Please click here to view a larger version of this figure.
Discussion
This is an easy, quick and less invasive technique that can be used in the out-patient clinics for relatively fast immune profiling in contrast to the conventional techniques like scraping, swabbing, pipetting or absorbent filter paper 1, 2 . A variant of this technique is already being used in research settings 22 . The future application of the proposed methodology is for patient stratification in clinical trials with ocular diseases, especially those requiring immunophenotyping.
A major challenge with this technique is the relatively few immune cells retrieved after impression collection and scraping. The total number of CD3 + T cells recovered from four impressions per individual varied from ~ 500 -1,000 cells. The ocular samples were washed before the flow cytometry analysis for a minimal number of times to avoid further loss of cells. Critical steps and challenges that remain within the protocol are efficient collection of ocular samples and proper scraping of the membrane to achieve higher cell numbers. Nevertheless, this limitation is unlikely to bias towards any specific immune phenotype. The troubleshooting performed here to maximize the yield of cells was to reduce the number of washing steps after and before the incubation of antibodies.
There are other limitations to using IC. In patients with severely keratinized or fibrosed ocular surface such as in Steven Johnson syndrome, the cellular yield may be even less than that in this study. The proportion of immune cells may change if the samples are stored instead of analyzed on the same day. It is difficult to predict if certain cell types are more resistant to storage than others. Previous studies have reported elevated levels of HLA-DR expression in the conjunctival epithelial cells 23 , so it would be interesting to evaluate the correlation between HLA-DR and levels of specific immune cells. Immune cells may also be associated with the expression level of chemokines. These issues should be addressed in future studies.
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